Status:
TERMINATED
Painless Subconjunctival Antibiotic and Antifungal Injection in Corneal Ulcer Patients
Lead Sponsor:
Mahidol University
Conditions:
Corneal Ulcer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The propose of this study is to determine the efficacy of 2% xylocaine in reducing pain due to subconjunctival antibiotic and antifungal injection.
Eligibility Criteria
Inclusion
- The corneal ulcer patients who are diagnosed by ophthalmologist and have 2 of 3 in these following features.
- corneal epithelial defect with stromal infiltration
- reaction in anterior chamber
- positive for bacteria or fungus
- The patients have to receive subconjunctival antibiotic injection twice at least.
- The patients must be informed consent.
Exclusion
- The patients who have history of allergy of local anesthetics, antibiotics or antifungal drugs.
- The patients who administered NSAIDs or weak opioids within 24 hours prior to subconjunctival antibiotic/antifungal injection.
- Unable to cooperate with the treatment.
- Pregnant women
Key Trial Info
Start Date :
June 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2009
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT00789646
Start Date
June 1 2008
End Date
June 1 2009
Last Update
March 12 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.